Both in Medical Labs
Caris Life Sciences vs GRAIL
Over the past year CAI returned +5.2% and GRAL returned +132.4%; their daily moves had a correlation of 0.31.
CAI +5.2% GRAL +132.4%Growth of $1, one year, split-adjusted
| Metric | CAI | GRAL |
|---|---|---|
| Price | $31.55 | $136.57 |
| Market cap | $8.92B | $6.10B |
| Today | −0.63% | +2.97% |
| 1 month | +23.1% | +70.7% |
| 6 months | +87.2% | +191.2% |
| Year to date | +16.9% | +59.6% |
| 1 year | +8.1% | — |
| Revenue growth (YoY) | +45.4% | +25.7% |
| Gross margin | 68.1% | −28.1% |
| Net margin | −0.2% | −246.7% |
| P/E (TTM) | 84.8× | — |
| Price / sales | 9.0× | 36.9× |
| Net cash | $400.0M | $861.6M |
| Dividend yield | — | — |
| Volatility (60d) | 71.3% | 93.0% |
| Short % of float | 14.1% | 20.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).